See & Cure !
R&D

  • No.
    Patent
    Country
    Application Number / Date
    Registration Number / Date
  • 20
    Pharmaceutical composition for prevention or treatment of cancer containing salmonella strain and immune checkpoint inhibitor as active ingredient
    PCT
    PCT/KR2022/017209 / 22.11.04.
  • 19
    Pharmaceutical composition for prevention or treatment of cancer containing salmonella strain and immune checkpoint inhibitor as active ingredient
    KR
    10-2022-0048063 / 22.04.19.
  • 18
    DNA construct for diagnosing and treating of cancer
    AU
    2020276121 / 21.11.10.
  • 17
    DNA construct for diagnosing and treating of cancer
    CA
    3136574 / 21.11.03.
  • 16
    DNA construct for diagnosing and treating of cancer
    JP
    2021-565714 / 21.11.01
  • 15
    DNA construct for diagnosing and treating of cancer
    CN
    202080035840.5 / 21.11.12.
  • 14
    DNA construct for diagnosing and treating of cancer
    EP
    20805424.7 / 21.11.05.
  • 13
    DNA construct for diagnosing and treating of cancer
    US
    17/610086 / 21.11.09.
  • 12
    Salmonella strain for treating cancer and use thereof
    KR
    10-2020-0074197 / 20.06.18.
    10-2327091 / 21.11.10.
  • 11
    DNA construct for diagnosing and treating of cancer
    KR
    10-2019-0055063 / 19.05.11.
    10-2252939 / 21.05.11.
  • 10
    Novel bacteria expressing hyaluronidase and use thereof
    KR
    10-2015-0065508 / 15.05.11.
    10-1733063 / 17.04.27.
  • 9
    Solid cancer tissue targeting bacterium and use thereof
    KR
    10-2015-0051085 / 15.04.10.
    10-1685034 / 16.12.05.
  • 8
    Solid cancer agent using bacteria
    KR
    10-2014-0132645 / 14.10.01.
    10-1750007 / 17.06.16.
  • 7
    Novel bacterial lysis protein and use thereof
    KR
    10-2011-0126747 / 11.11.30.
    10-1346620 / 13.12.24.
  • 6
    Selective infarcted-tissue-targeting bacteria and use thereof
    CH
    2436756 / 16.08.17.
  • 5
    Selective infarcted-tissue-targeting bacteria and use thereof
    DE
    60 2010 035 652.3 / 16.08.17.
  • 4
    Selective infarcted-tissue-targeting bacteria and use thereof
    GB
    2436756 / 16.08.17.
  • 3
    Selective infarcted-tissue-targeting bacteria and use thereof
    EP
    10780812 / 11.12.16.
    2436756 / 16.08.17.
  • 2
    Selective infarcted-tissue-targeting bacteria and use thereof
    US
    13/322637 / 11.11.30.
    9339018 / 06.05.17.
  • 1
    Selective infarcted-tissue-targeting bacteria and use thereof
    KR
    10-2011-7028233 / 11.11.25.
    10-1711399 / 17.02.23.